Daily FNArena News

Brokers were generally nonplussed by the Sigma Pharmaceuticals interim result as margins in the generic business remain a concern and an impediment to group earnings growth.

Not just China, but Asia as a whole has been an important driver of the global recovery to date. Can this trend continue?

Primary Health Care is to refinance $1.2bn in debt and the move is seen as removing a perceived overhang.

Evidence abounds that a recovery is brewing, but policy makers in the West and East need to be aware they still have an important part to play.

The next move in official interest rates in New Zealand will be up.

Weekly musings from your editor. If ever there was a powerful argument about the share market, this would be the one.

In the view of Barclays Capital commodity markets generally are in a period of consolidation before the uptrend resumes.

While there is a host of equally important reads on the health and prospects of an economy, this time around US Employment is at the tops of the list.

Australia’s unemployment rate was unchanged at 5.8% in August but the details tell a different tale.

DAP prices are improving but has the market overpriced Incitec?